Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Calgary

$135,000.00

Studying mesenchymal-epithelial transition mechanism using an in vitro 3D model of tumorigenesis

FY 2012-13

Summary
The transformation of a cancer cell into a metastatic body is the main cause of death in patients with cancer. Cancer stem cells have the ability to give rise to all cell types found in a particular cancer sample, and therefore these cells are tumorigenic. Cancer stem cells are proposed to persist in tumours as a distinct subpopulation and cause relapse and metastasis by giving rise to secondary tumours. It is suggested that by selectively targeting cancer stem cells it would be possible to treat patients with aggressive tumors and prevent metastasis. Our research project proposes a model of tumour formation that will allow us to study cancer stem cell tumour development in three dimensional (3D) tissue culture. It can further be used for high throughput small molecule screening for drugs that suppress tumour formation. Recently researchers have called for better cancer models where tumour formation can be studied in 3D culture within a tissue context. Our approach can lead to a new field of cancer tissue engineering, which will allow the study of cancer stem cells mediated tumour formation in culture. Engineered tissues provide physiologically relevant, yet controllable models for the fundamental research, for example, to study stem cells in native-like 3D context of the development or a disease, or to perform drug screening with engineered human tissues. Development of specific therapies targeted at cancer stem cells has a great potential for improvement of survival and quality of life of cancer metastatic patients. Our research will contribute significantly to the understanding of the mechanism and regulation of cancer stem cell tumour development and provide a valuable 3D model of tumour formation.
Program
CIHR Fellowship
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
279930
Name
Shulga Yulia
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Studying mesenchymal-epithelial transition mechanism using an in vitro 3D model of tumorigenesis
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
3d Tissue Culture; Cancer Research; Cancer Stem Cells; Confocal Microscopy; Immunohistochemistry; Induced Pluripotent Stem Cells; Mesenchymal-Epithelial Transition; Real-Time Rt-Pcr; Tissue Engineering; Tumour Models
Abstract
The transformation of a cancer cell into a metastatic body is the main cause of death in patients with cancer. Cancer stem cells have the ability to give rise to all cell types found in a particular cancer sample, and therefore these cells are tumorigenic. Cancer stem cells are proposed to persist in tumours as a distinct subpopulation and cause relapse and metastasis by giving rise to secondary tumours. It is suggested that by selectively targeting cancer stem cells it would be possible to treat patients with aggressive tumors and prevent metastasis. Our research project proposes a model of tumour formation that will allow us to study cancer stem cell tumour development in three dimensional (3D) tissue culture. It can further be used for high throughput small molecule screening for drugs that suppress tumour formation. Recently researchers have called for better cancer models where tumour formation can be studied in 3D culture within a tissue context. Our approach can lead to a new field of cancer tissue engineering, which will allow the study of cancer stem cells mediated tumour formation in culture. Engineered tissues provide physiologically relevant, yet controllable models for the fundamental research, for example, to study stem cells in native-like 3D context of the development or a disease, or to perform drug screening with engineered human tissues. Development of specific therapies targeted at cancer stem cells has a great potential for improvement of survival and quality of life of cancer metastatic patients. Our research will contribute significantly to the understanding of the mechanism and regulation of cancer stem cell tumour development and provide a valuable 3D model of tumour formation.
Competitiondate
201302
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Shulga, Yulia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~